Intratracheal administration of interleukin 12 plasmid - Cationic lipid complexes inhibits murine lung metastases

Human Gene Therapy

Volumn 10, Issue 5, 1999, Pages 723-731

  Blezinger, Paul ^a   Freimark, Bruce D ^a   Matar, Majed ^a   Wilson, Elizabeth ^a   Singhal, Arun ^a   Min, Wang ^a   Nordstrom, Jeffrey L ^a   Pericle, Federica ^a  

^a GeneMedicine Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; FEMALE; GENE THERAPY; KIDNEY CARCINOMA; LUNG LAVAGE; LUNG METASTASIS; MOUSE; NONHUMAN;

ANIMALS; FEMALE; GREEN FLUORESCENT PROTEINS; INTERFERON TYPE II; INTERLEUKIN-12; LIPIDS; LIPOSOMES; LUMINESCENT PROTEINS; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MODELS, GENETIC; PLASMIDS; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0033586318     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018481     Document Type: Article

References (35)

1. ALILA, H., COLEMAN, M., NITTA, H., FRENCH, M., ANWER, K., LIU, Q., MEYER, T., WANG, J., MUMPER, R., OUBARI, D., LONG, S., NORDSTROM, J., and ROLLAND, A. (1997). Expression of biologically active human insulin-like growth factor-1 following intramuscular injection of a formulated plasmid in rats. Hum. Gene Ther. 8, 1785-1795.
2. ALTON, E.W.F.W., MIDDLETON, P.G., CAPLEN, N.J., SMITH, S.N., STEEL, D.M., MUNKONGE, F.M., JEFFREY, P.K., GEDDES, D.M., HART, S.L., WILLIAMSON, R., FASOLD, K.I., MILLER, A.D., DICKINSON, P., STEVENSON, B.J., MCLACHLAN, G., DORIN, J.R., and PORTEOUS, D.J. (1993). Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nature Genet. 5, 135-142.
3. BRAMSON, J.L., HITT, M., ADDISON, C.L., MULLER, W.J., CAULDIE, J., and GRAHAM, F.L. (1996). Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Hum. Gene Ther. 7, 1995-2002.
4. BRIGHAM, K.L., MEYRICK, B., CHRISTMAN, B., MAGNUSON, M., KING, G., and BERRY, L.C., JR. (1989). Rapid communication: In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am. J. Med. Sci. 298, 278-281.
5. BRUNDA, M.J., LUISTRO, L., WARRIER, R.R., WRIGHT, R.B., HUBBARD, B.R., MURPHY, M., WOLF, S.F., and GATELY, M.K. (1993). Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178, 1223-1230.
6. BRUNDA, M.J., LUISTRO, L., HENDRZAK, J.A., FOUNTOULAKIS, M., GAROTTA, G., and GATELY, M.K. (1995). Role of interferon-γ in mediating the antitumor efficacy of interleukin-12. J. Immunol. 17, 71-77.
7. CANONICO, A.E., CONARY, J.T., MEYRICK, B.O., and BRIGHAM, K.L. (1994). Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits. Am. J. Respir. Cell Mol. Biol. 10, 24-29.
8. COHEN, J. (1995). IL-12 deaths: Explanation and a puzzle. Science 270, 908.
9. COLOMBO, M.P., MODESTI, A., PARMIANI, G., and FORNI, G. (1992). Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res. 52, 4853-4857.
10. DESHPANDE, D., BLEZINGER, P., PILLAI, R., DUGUI, J., FREIMARK, B., and ROLLAND, A. (1998). Target specific modulation of cationic lipid-based system for pulmonary gene therapy. Pharm. Res. 9, 1340-1347.
11. EISSA, N.T., CHU, C.S., DANEL, C., and CRYSTAL, R.G. (1994). Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1 a sequences relevant to the use of E1a-adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis. Hum. Gene Ther. 5, 1105-1114.
12. FORNI, G., GIOVARELLI, M., CAVALLO, F., CONSALVO, M., ALLIONE, A., MODESTI, A., MUSIANI, P., and COLOMBO, M.P. (1993). Cytokine-induced tumor immunogenicity: From exogenous cytokines to gene therapy. J. Immunol. 14, 253-257.
13. FREIMARK, B.D., BLEZINGER, H.P., FLORACK, V.J., NORDSTROM, J.L., LONG, S.D., DESHPANDE, D.S., NOCHUMSON, S., and PETRAK, K.L. (1998). Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: Cationic lipid complexes. J. Immunol. 160, 4580-4586.
14. IRVINE, K.R., RAO, J.B., ROSENBERG, S.A., and RESTIFO, N.P. (1996). Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156, 238-245.
15. KHANA, C., WALDREP, J.C., ANDERSON, P.M., WEISCHELBAUM, R.W., HASZ, D.E., KATSANIS, E., and KLAUSNER, J.S. (1997). Nebulized interleukin 2 liposomes: Aerosol characteristics and biodistribution. J. Pharm. Pharmacol. 49, 960-971.
16. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B., and TRINCHIERI, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170, 827-845.
17. KOOP, S., MACDONALD, I.C., LUZZI, K., SCHMIDT, E.E., MORRIS, V.L., GRATTAN, M., KHOKHA, R., CHAMBERS, A.F., and GROOM, A.C. (1995). Fate of melanoma cells entering the microcirculation: Over 80% survive and extravasate. Cancer Res. 54, 4791-4797.
18. MARSHALL, E. (1995). Cancer trial of interleukin-12 halted. Science 268, 1555.
19. MEYER, K.B., THOMPSON, M.M., LEVY, M.Y., BARRON, L.G., and SZOKA, F.C. (1995). Intratracheal gene delivery to the mouse airway: Characterization of plasmid DNA expression and pharmacokinetics. Gene Ther. 2, 450-460.
20. MEYERS, J.N., MANK-SEYMOUR, A., ZITVOGEL, L., STORKUS, W., CLARKE, M., JOHNSON, C.S., TAHARA, H., and LOTZE, M.T. (1998). Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H mice. Laryngology 108, 261-268.
21. NASTALA, C.L., EDINGTON, H.D., MCKINNEY, T.G., TAHARA, H., NALESNIK, M.A., BRUNDA, M.J., GATELY, M.K., WOLF, S.F., SCHREIBER, R.D., STORKUS, W.J., and LOTZE, M. (1994). Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153, 1697-1706.
22. PARDOLL, D.M. (1995). Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 13, 339-415.
23. RAKHMILEVICH, A.L., TURNER, J., FORD, M.J., MCCABE, D., SUN, W.H., SONDEL, P.M., GROTA, K., and YANG, N.S. (1996). Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc. Natl. Acad. Sci. U.S.A. 93, 6291-6296.
24. RAKHMILEVICH, A.L., JANSSEN, K., TURNER, J., CULP, J., and YANG, N. (1997). Cytokine gene therapy of cancer using gene gun technology: Superior antitumor activity of interleukin-12. Hum. Gene Ther. 8, 1303-1311.
25. SARMIENTO, U.M., RILEY, J.H., KNAACK, P.A., LIPMAN, J.M., BECKER, J.M., GATELY, M.K., CHIZZONITE, R., and ANDERSON, T.D. (1994). Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri). Lab. Invest. 71, 862-873.
26. SIDERS, W.M., WRIGHT, P.W., HIXON, J.A., ALVORD, W.G., BACK, T.C., WILTROUT, R.H., and FENTON, R.G. (1998). T cell- and NK cell-independent inhibition of hepatic metastases by system administration of an IL-12-expressing recombinant adenovirus. J. Immunol. 160, 5465-5474.
27. STRIBLING, R., BRUNETTE, E., LIGGITT, D., GAENSLER, K., and DEBS, R. (1992). Aerosol gene delivery in vivo. Proc. Natl. Acad. Sci. U.S.A. 89, 11277-11281.
28. SUN, Y., JURGOVSKY, K., MOLLER, P., ALIJAGIC, S., DORBIC, S., GEORGIEVA, J., WITTIG, B., and SCHADENDORF, D. (1998). Vaccination with IL-12 gene-modified autologous melanoma cells: Preclinical results and a first clinical phase 1 study. Gene Ther. 5, 481-490.
29. TAN, J., NEWTON, C.A., DJEU, J.Y., GUTSCH, D.E., CHANG, A.E., YANG, N., KELIN, T.W., and YU, H. (1996). Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Res. 56, 3399-3403.
30. TANNENBAUM, C.S., WICKER, N., ARMSTRONG, D., TUBBS, R., FINKE, J., BUKOWSKI, R.M., and HAMILTON, T.A. (1996). Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J. Immunol. 156, 693-699.
31. TARE, N.S., BOWEN, S., WARRIER, R.W., CARVAJAL, D.M., BENJAMIN, W.R., RILEY, J.H., ANDERSON, T.D., and GATELY, M.K. (1995). Administration of recombinant interleukin-12 to mice suppresses hematopoiesis in the bone marrow but enhances hematopoiesis in the spleen. J. Interferon Cytokine Res. 15, 377-383.
32. TRINCHIERI, G. (1993). Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today 14, 335-338.
33. TRINCHIERI, G. (1995). Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008-4027.
34. WELSH, M.J., SMITH, A.E., ZABNER, J., RICH, D.P., GRAHAM, S.M., GREGORY, R.J., PRATT, B.M., and MOSCICKI, R.A. (1994). Cystic fibrosis gene therapy using an adenovirus vector: In vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5, 209-219.
35. YOSHIMURA, K., ROSENFELD, M.A., NAKAMURA, H., SCHERER, E.M., PAVIRANI, A., LECOCQ, J., and CRYSTAL, R.G. (1992). Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res. 20, 3233-3240.